Picking Battles in the $5 Trillion Healthcare Market: with David Berry, the Elon Musk of Biotech

In this episode of Billion Dollar Moves, I sit down with David Berry, Co-Founder and Managing Partner of Averin Capital, for a conversation about building billion-dollar breakthroughs in healthcare.

David has founded more than 30 companies, including seven valued over $1B, and has helped shape companies across biotech, AI drug discovery, microbiome therapeutics, agriculture, and health infrastructure.

From losing a childhood friend to brain cancer, to asking why the hardest problems are worth pursuing, David shares how mission, science, and capital come together to create venture-scale healthcare companies.

For founders, funders, and family offices investing in the future of health, this is a conversation about conviction, ethics, and building for impact at scale.

Watch the full conversation and subscribe for more discussions at the intersection of capital, governance, and long-term wealth.

00:00 - Intro: Why go after the biggest problems?

01:12 - Truth vs. belief in science

03:00 - The myth that humans only use 10% of their brains

04:28 - Rethinking cancer and inherited assumptions

05:38 - How big ideas emerge from questioning “truth”

06:30 - Entrepreneur vs. investor: The N of one

08:10 - Building Seres Therapeutics and the microbiome frontier